RIO DE JANEIRO, BRAZIL - Peru’s health minister said on Tuesday, January 5th, that “controversy” had arisen over a liability waiver in the country’s negotiations to obtain COVID-19 vaccines from Pfizer Inc.
Pilar Mazzetti told Congress that Peruvian officials had been in “constant contact” with Pfizer since July but that a dispute arose in their negotiations in December.
She said she could not give details because of a confidentiality agreement but added that they related to “the waiving of important elements such as ... jurisdictional immunity.”
“It is true that one needs the vaccine but it is also true . . .